SCT-001 CAR T Cells Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SCT-001 CAR T Cells Therapy, covering 2025-02-26 to 2025-02-26. Get the full timeline:
Most recent: Clinical Trial Update: SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer [Phase 1]